These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

194 related articles for article (PubMed ID: 17388708)

  • 1. Atomoxetine in the treatment of binge-eating disorder: a randomized placebo-controlled trial.
    McElroy SL; Guerdjikova A; Kotwal R; Welge JA; Nelson EB; Lake KA; Keck PE; Hudson JI
    J Clin Psychiatry; 2007 Mar; 68(3):390-8. PubMed ID: 17388708
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Zonisamide in the treatment of binge eating disorder with obesity: a randomized controlled trial.
    McElroy SL; Kotwal R; Guerdjikova AI; Welge JA; Nelson EB; Lake KA; D'Alessio DA; Keck PE; Hudson JI
    J Clin Psychiatry; 2006 Dec; 67(12):1897-906. PubMed ID: 17194267
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Once-daily atomoxetine for adult attention-deficit/hyperactivity disorder: a 6-month, double-blind trial.
    Adler LA; Spencer T; Brown TE; Holdnack J; Saylor K; Schuh K; Trzepacz PT; Williams DW; Kelsey D
    J Clin Psychopharmacol; 2009 Feb; 29(1):44-50. PubMed ID: 19142107
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A randomized, double-blind, placebo-controlled clinical trial on once-daily atomoxetine in Taiwanese children and adolescents with attention-deficit/hyperactivity disorder.
    Gau SS; Huang YS; Soong WT; Chou MC; Chou WJ; Shang CY; Tseng WL; Allen AJ; Lee P
    J Child Adolesc Psychopharmacol; 2007 Aug; 17(4):447-60. PubMed ID: 17822340
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Zonisamide in the treatment of binge-eating disorder: an open-label, prospective trial.
    McElroy SL; Kotwal R; Hudson JI; Nelson EB; Keck PE
    J Clin Psychiatry; 2004 Jan; 65(1):50-6. PubMed ID: 14744168
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Citalopram in the treatment of binge-eating disorder: a placebo-controlled trial.
    McElroy SL; Hudson JI; Malhotra S; Welge JA; Nelson EB; Keck PE
    J Clin Psychiatry; 2003 Jul; 64(7):807-13. PubMed ID: 12934982
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Double-blind, randomized, placebo-controlled trial of topiramate plus cognitive-behavior therapy in binge-eating disorder.
    Claudino AM; de Oliveira IR; Appolinario JC; Cordás TA; Duchesne M; Sichieri R; Bacaltchuk J
    J Clin Psychiatry; 2007 Sep; 68(9):1324-32. PubMed ID: 17915969
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Efficacy of sibutramine for the treatment of binge eating disorder: a randomized multicenter placebo-controlled double-blind study.
    Wilfley DE; Crow SJ; Hudson JI; Mitchell JE; Berkowitz RI; Blakesley V; Walsh BT;
    Am J Psychiatry; 2008 Jan; 165(1):51-8. PubMed ID: 18056225
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Atomoxetine: a review of its use in adults with attention deficit hyperactivity disorder.
    Simpson D; Plosker GL
    Drugs; 2004; 64(2):205-22. PubMed ID: 14717619
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Efficacy and Safety of Dasotraline in Adults With Binge-Eating Disorder: A Randomized, Placebo-Controlled, Flexible-Dose Clinical Trial.
    McElroy SL; Hudson JI; Grilo CM; Guerdjikova AI; Deng L; Koblan KS; Goldman R; Navia B; Hopkins S; Loebel A
    J Clin Psychiatry; 2020 Sep; 81(5):. PubMed ID: 32926604
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Topiramate in the treatment of binge eating disorder associated with obesity: a randomized, placebo-controlled trial.
    McElroy SL; Arnold LM; Shapira NA; Keck PE; Rosenthal NR; Karim MR; Kamin M; Hudson JI
    Am J Psychiatry; 2003 Feb; 160(2):255-61. PubMed ID: 12562571
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Atomoxetine for weight reduction in obese women: a preliminary randomised controlled trial.
    Gadde KM; Yonish GM; Wagner HR; Foust MS; Allison DB
    Int J Obes (Lond); 2006 Jul; 30(7):1138-42. PubMed ID: 16418753
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Placebo-controlled trial of atomoxetine for weight reduction in people with schizophrenia treated with clozapine or olanzapine.
    Ball MP; Warren KR; Feldman S; McMahon RP; Kelly DL; Buchanan RW
    Clin Schizophr Relat Psychoses; 2011 Apr; 5(1):17-25. PubMed ID: 21459735
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Atomoxetine versus placebo in children and adolescents with attention-deficit/hyperactivity disorder and comorbid oppositional defiant disorder: a double-blind, randomized, multicenter trial in Germany.
    Dittmann RW; Schacht A; Helsberg K; Schneider-Fresenius C; Lehmann M; Lehmkuhl G; Wehmeier PM
    J Child Adolesc Psychopharmacol; 2011 Apr; 21(2):97-110. PubMed ID: 21488751
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A randomized double-blind study of atomoxetine versus placebo for attention-deficit/hyperactivity disorder symptoms in children with autism spectrum disorder.
    Harfterkamp M; van de Loo-Neus G; Minderaa RB; van der Gaag RJ; Escobar R; Schacht A; Pamulapati S; Buitelaar JK; Hoekstra PJ
    J Am Acad Child Adolesc Psychiatry; 2012 Jul; 51(7):733-41. PubMed ID: 22721596
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Once-daily atomoxetine treatment for children with attention-deficit/hyperactivity disorder, including an assessment of evening and morning behavior: a double-blind, placebo-controlled trial.
    Kelsey DK; Sumner CR; Casat CD; Coury DL; Quintana H; Saylor KE; Sutton VK; Gonzales J; Malcolm SK; Schuh KJ; Allen AJ
    Pediatrics; 2004 Jul; 114(1):e1-8. PubMed ID: 15231966
    [TBL] [Abstract][Full Text] [Related]  

  • 17. High-dose escitalopram in the treatment of binge-eating disorder with obesity: a placebo-controlled monotherapy trial.
    Guerdjikova AI; McElroy SL; Kotwal R; Welge JA; Nelson E; Lake K; Alessio DD; Keck PE; Hudson JI
    Hum Psychopharmacol; 2008 Jan; 23(1):1-11. PubMed ID: 18058852
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Spotlight on atomoxetine in adults with attention-deficit hyperactivity disorder.
    Simpson D; Plosker GL
    CNS Drugs; 2004; 18(6):397-401. PubMed ID: 15089111
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A randomized, double-blind, placebo-controlled study of sibutramine in the treatment of binge-eating disorder.
    Appolinario JC; Bacaltchuk J; Sichieri R; Claudino AM; Godoy-Matos A; Morgan C; Zanella MT; Coutinho W
    Arch Gen Psychiatry; 2003 Nov; 60(11):1109-16. PubMed ID: 14609886
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Atomoxetine hydrochloride in the treatment of children and adolescents with attention-deficit/hyperactivity disorder and comorbid oppositional defiant disorder: A placebo-controlled Italian study.
    Dell'Agnello G; Maschietto D; Bravaccio C; Calamoneri F; Masi G; Curatolo P; Besana D; Mancini F; Rossi A; Poole L; Escobar R; Zuddas A;
    Eur Neuropsychopharmacol; 2009 Nov; 19(11):822-34. PubMed ID: 19716683
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.